TD Cowen analyst Gary Taylor lowered the firm’s price target on LifeStance to $6 from $9 and keeps a Market Perform rating on the shares. The firm continues to cite progress in its operational turnaround and maintains its 2025 margin outlook but the slope of margin improvement has us moderating EBITDA modestly over 2023-2035
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LFST:
- LifeStance Reports Third Quarter 2023 Results
- LifeStance sees FY23 revenue $1.03B-$1.04B, consensus $1.03B
- LifeStance sees Q4 revenue $255M-$265M, consensus $261.98M
- LifeStance reports Q3 EPS (17c), consensus (8c)
- Morgan Stanley Predicts at Least 70% Upside for These 2 High-Conviction Stocks — They Have Upcoming Catalysts and Strong Growth Prospects
